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ACUTE NONGONOCOCCAL INFECTIOUS ARTHRITIS 
Evaluation of Risk Factors, Therapy, and Outcome 
JEROME ROSENTHAL, GILES G. BOLE, and WILLIAM D. ROBINSON 
A retrospective analysis of 71 nongonococcal 
joint infections in 63 patients is reported. Staphylococ- 
cus uureus was isolated from 59% of the patients. Five 
patients died as a result of infections. The outcome in 
Gram-negative joint infections was similar to the overall 
outcome in the entire series of patients. All 11 joints 
with infected prostheses ultimately required removal of 
the prostheses. All patients were treated with appropri- 
ate parenteral antibiotics, and surgical intervention was 
used in 40 joints. Six patients underwent surgical treat- 
ment because of inability to sterilize the joint with anti- 
biotics and because of repeated joint aspirations. The 
outcome with surgical intervention was good only in pa- 
tients younger than 16 years of age. Medical therapy 
(parenteral antibiotics and frequent joint aspirations) 
led to good results in 74% of the patients. Outcome of 
joint infection was also influenced by factors which con- 
tribute to impaired host resistance. 
Nongonococcal acute infectious arthritis contin- 
ues to present a therapeutic challenge, with a poor prog- 
nosis in approximately 50% of cases. In some subgroups 
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the mortality rate approaches 20%. During the last 20 
years, the incidence appears to have remained essen- 
tially constant (1,2). The coagulase positive staphylo- 
coccus continues to be the most common infecting 
organism, accounting for more than 50% of cases in cer- 
tain studies (3,4) and between 30% and 50% in others 
(5,6). Other Gram-positive cocci are the next most fre- 
quent cause of infection, while the pneumococcus is an 
infrequent cause of acute infectious arthritis (7). 
In recent years, there has been an increased 
number of reports documenting the occurrences of in- 
fectious arthritis caused by Gram-negative organisms 
(8-1 8). Hemophilus infuenzae infectious arthritis is 
more common in young children, but it also occurs in 
adults (15). Salmonella infections have been reported 
less frequently (18). Intravenous drug abusers have a 
special predilection for Gram-negative infections with a 
high incidence of involvement of the sternoclavicular 
joint (8,9,12,13). Almost any joint can be infected with 
Gram-positive or Gram-negative organisms (19), but 
the knee and hip remain the most commonly infected 
joints (1,2). 
The current retrospective study was undertaken 
to determine whether the ability to diagnose and treat 
nongonococcal infectious arthritis has improved in re- 
cent years. Particular attention has been directed to the 
identification of major factors which influence progno- 
sis and to defining specific subgroups of patients with 
characteristics that might alter the outcome of the infec- 
tion. 
PATIENTS AND METHODS 
The medical records of all patients with a primary or 
secondary diagnosis of infectious arthritis discharged from 
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University Hospital between January 1, 1972 and December 
31, 1977 were reviewed. Sixty-three cases were found to satisfy 
one of the following criteria: 1) positive synovial fluid cultures 
(60 patients); 2) a clinically infected joint with positive blood 
cultures and negative synovial fluid cultures (2 patients). One 
additional patient with H injuenzae meningitis and negative 
synovial fluid and blood cultures was included, since H in- 
jluenzae antigen was detected by counterimmunoelec- 
trophoresis of synovial fluid obtained from a clinically in- 
fected joint. Nine patients diagnosed as having acute 
infectious arthritis on clinical grounds only have been ex- 
cluded from this series since blood and synovial fluid cultures 
were negative. During the same 6-year period, 27 patients 
with gonococcal arthritis were admitted to University Hospi- 
tal; these patients were not included in the present study. 
Student's t-test and chi-square analyses were used to 
test for statistical significance. 
RESULTS 
Patient population. There were 32 males and 31 
females with a mean age of 35.5 years; 12 patients were 
less than 4 years old (Table 1). Thirty-three patients 
were admitted to the Surgery Service, and 30 to the In- 
ternal Medicine or Pediatric Services. Fourteen patients 
were taking oral corticosteroids (greater than 10 mg 
prednisone/day or equivalent); 3 patients were receiv- 
ing other immunosuppressive agents. Four had chronic 
debilitating illnesses (diabetes, alcoholism, or malig- 
nancy), and 9 had rheumatoid arthritis. In 9 patients, 
the infection was superimposed on joints containing 
prostheses. 
A total of 7 1 joint infections were observed in the 
63 patients included in this series (Table 2). Twenty pa- 
tients were 15 years of age or less. All pediatric patients 
had monarticular disease; 60% had hip involvement and 
35% had knee infections. In the adult age group, there 
were 2 patients with two joints involved, 2 with three 
joints involved, and 1 patient with the same joint in- 
fected on three separate occasions. The 4 patients with 
multiple joint infections all had a chronic underlying 
disease: 3 had rheumatoid arthritis and 1 had systemic 
Table 1. Age in years at time of onset of nongonococcal joint infection 
in 63 patients 

















Table 2. Distribution of 7 1 joints involved with nongonococcal infec- 







































Totals 20 51  71 
~~ 
* MTP/MCP = metatarsophalangeal/metacarpophalangeal. 
lupus erythematosus. Nine patients with prosthetic 
joints had a total of 11 infections. 
The average duration of symptoms before diag- 
nosis was 14 days (range 1-180 days). The mean dura- 
tion of symptoms in patients with rheumatoid arthritis 
(excluding patients with prostheses) was 14 days (range 
3-30 days) and in those with prosthetic joints 28 days 
(range 4-90 days). Two patients with infected pros- 
theses had symptoms for 3 months before the diagnosis 
of joint infection was established. 
The presence of warmth of the infected joint was 
recorded in 13 cases, erythema was noted in 9, swelling 
in 32, and pain in 48. All four symptoms were present in 
6 patients. Fever (oral temperature >100"F) was ini- 
tially present in 56% of all patients. 
Organisms. Eighty-seven different organisms 
Table 3. Organisms cultured from infected joints in 63 patients* 
Organism No. joints 
Gram-positive cocci (aerobic), 56 
Staphylococcus aureus 40 
Staphylococcus epidermidis 6 
Aerobic Streptococcus 6 















* More than one organism was isolated from 11 joints. 
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were cultured from the 71 infected joints (Table 3). 
Eleven patients had more than one organism isolated 
from their joint(s). In 3 cases, the second organism was 
a coagulase negative Staphylococcus. Staphylococcus 
aureus was isolated from 59% of the patients. Other 
aerobic Gram-positive cocci isolated were Strepto- 
coccus 6, group D Enterococcus 3, and Micrococcus 1. 
Anaerobes isolated from infected joints were Bacte- 
roides species 3, Clostridium species 2, Peptostrepto- 
coccus 2, and Propionibacterium acnes 1. 
Sixteen patients had joint infections with 23 dif- 
ferent Gram-negative organisms. E coli was the most 
frequent isolate (9 patients), followed by Proteus 4, 
Pseudomonas 3, Hemophilus 3, Klebsiella 2, and Ser- 
ratia and Aeromonas 1 each. 
In the 20 patients in the pediatric age group, co- 
agulase-positive staphylococci were responsible for 14 
infections. All three Hemophilus infruenzae infections 
were in this age group (1, 3, and 15 years old). There 
were no other Gram-negative organisms responsible for 
infection in this group. Streptococcus was the infecting 
organism in 2 patients and Propionobacterium acnes in 
one. A coagulase-negative Staphylococcus was isolated 
along with a Streptococcus from one infected joint. 
Blood cultures were positive in 13 (34%) of the 
38 patients from whom they were obtained. 
A primary source for acute infectious arthritis 
was found in 34 of the 63 patients (54%). The primary 
source of infection was the genitourinary tract in 6 pa- 
tients, chronic osteomyelitis in 6 patients, skin abcesses 
in 4 patients, and intravenous drug abuse in 4 patients. 
Other sources of infection were intraarticular injections 
3, chronic draining sinuses 2 (both from joint prostheses 
that had drained since surgery), decubiti 2, and abdomi- 
nal visceral rupture 2. Otitis media, cellulitis, pharyn- 
gitis, meningitis, and infected femoral popliteal bypass 
was the source in one patient each. The most common 
source of infection in Gram-negative infections was the 
genitourinary tract (4 patients). 
Laboratory data. The average synovial fluid 
white cell count was 132,400 per mm3 (range 3,600- 
905,000). One patient had an initial synovial fluid white 
count less than 25,000 per mm3 and had been on antibi- 
otics prior to the development of joint infection. The av- 
erage peripheral white cell count was 11,000 per mm3 
(range 450-26,700 per mm3). Twenty-four patients had 
normal peripheral total white blood cell counts, while 2 
patients had leukopenia of less than 3,000 white cells 
per mm’. Differential white cell counts demonstrated an 
increase in immature neutrophils in 21 of 37 patients 
(58%). 
Treatment. Forty joints were treated with par- 
enteral antibiotics and open surgical drainage and/or 
removal of an infected prosthesis. Thirty-one joints 
were treated with parenteral antibiotics and repeated as- 
piration of the joint space to remove purulent material 
(Table 4). The surgically treated group included 6 pa- 
tients who were considered medical failures (i.e., the in- 
fected joint could not be sterilized after repeated joint 
aspirations and use of systemic antibiotic therapy). All 
of these patients had joint aspirations at a minimum of 
every other day for at least 5 days, combined with high- 
dose parenteral antibiotics. 
Mortality. Five patients died as a direct result of 
sepsis (Table 5). All the deaths were in patients with se- 
vere impairment of host resistance. One neonate was 12 
weeks premature and had a patent ductus arteriosus 
and a bilirubin of over 20 mg/dl. Other fatalities oc- 
curred in patients in their sixties who had other chronic 
underlying disease. One patient died 15 months after di- 
agnosis of acute infectious arthritis as a result of septic 
shock due to the same organism. 
Outcome. Followup data were obtained from 56 
of 63 patients who had a total of 64 infected joints. A 
good outcome was defined as complete recovery and/or 
the absence of any of the criteria that defined a poor 
outcome. A poor outcome was defined as: 1) greater 
than 10% reduction in range of motion of the involved 
joint compared to the patient’s pre-morbid state; 2) in- 
fections resulting in a chronically draining abscess; 3) 
removal of an infected joint prosthesis with a sub- 
sequent arthrodesis; 4) recurrent joint infection with the 
same organism; 5) severe chronic articular pain or an 
unstable, irritable joint; or 6) death related to the in- 
fected joint. Medical therapy consisted of parenteral an- 
tibiotics and repeated local joint aspiration. Surgical 
therapy consisted of parenteral antibiotics and open 
Table 4. Treatment of 71 joints involved in nongonococcal infectious 







































Total 31 40 71 
* Numbers in parentheses indicate prosthetic joints. 
t Metatarsophalangeal/metacarpophalangeal. 
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Table 5. Mortality related to nongonococcal infectious arthritis 
Patient’s age Organism Joint Underlying diseases Treatment 
27 days S auras  Knee 12 weeks premature; bilirubin Medical 
66 years S auras  Knee Rheumatoid arthritis for 8 Surgical 
markedly elevated 
years; on prednisone, 11 mg/day 
or more for several years 
methasone, 12 mg/day for 6 
weeks prior to onset of infected joint 
nectomy; receiving chemo- 
therapy (last course 2 
weeks prior to onset ofjoint 
infection); leukopenic for I 
week prior to admission 
alcohol abuse; on cortico- 
steroids (dose unknown). Died 
15 months after discharge 
due to E coli septicemia 
64 years S auras  Knee Cerebellar hemangioma; dexa- Medical 
61 years E coli Hip Lymphoma; previous sple- Medical 
64 years E coli Hip Gouty arthritis with chronic Medical 
surgical drainage (and/or removal of an infected pros- 
thesis). 
The clinical outcome of patients in this series is 
summarized in Table 6. Twelve of the 37 (32%) joint in- 
fections treated by open surgical drainage had good re- 
sults, as defined previously, whereas 25 of 37 (68%) had 
poor results, as defined previously. When the 11 in- 
fected prosthetic joints are excluded, 12 of 26 (46%) had 
poor outcomes. By comparison, 20 of 27 (74%) patients 
who were treated with antibiotic therapy and repeated 
needle aspiration of the joint had good results. Surgi- 
cally treated patients who had good outcomes all had 
monarticular infections. Their average age was 5.5 
years, and the oldest was 16 years. In contrast, the aver- 
age age of surgically treated patients with poor out- 
comes was 45.9 years. This is highly significant (P < 
Table 6. Clinical outcome related to method of treatment 
Surgical therapy* Medical therapy? 
Good Poor Good Poor Total* 
Knee 2 15 (7) 9 3 29 
Ankle I 1 2 0 4 
wrist 0 2 0 1 3 
Elbow 0 0 2 1 3 
Shoulder 0 0 1 0 I 
Total 12 25 20 7 64 
Hip 9 7 (4) 3 2 21 
MTP/MCP§ 0 0 3 0 3 
* Parenteral antibiotics and open drainage. Numbers in parentheses 
t Parenteral antibiotics and joint aspirations. 
$ Seven patients were lost to followup (5 medically treated, 2 surgi- 
8 Metatarsophalangeal/metacarpophalangeal. 
indicate prosthetic joints. 
cally treated). 
0.001). The average age of the medically treated groups 
with good and poor outcomes was 38.9 years and 42 
years, respectively. 
The mean duration of symptoms in medically 
treated patients who were classified as having a good 
outcome was 13.5 days (range 1-60 days); in surgically 
treated patients with a good outcome, it was 7 days 
(range 1-21 days). In patients with poor results who 
were treated medically, the average duration of symp- 
toms was 8.4 days (range 1-21 days). For surgically 
treated patients with poor outcomes, the average dura- 
tion of symptoms (excluding infected prostheses) was 
18.5 days (range 1-180 days). These differences in pre- 
treatment duration of symptoms were not statistically 
significant when the single patient with a duration of 
180 days is excluded. 
All patients were initially treated with appropri- 
ate parenteral antibiotics, regardless of other therapy. 
Surgically managed patients with good results received 
an average of 19.75 days of parenteral antibiotics; surgi- 
cally managed patients with poor outcomes received 
14.3 days of parenteral antibiotic therapy (P > 0.05). 
Medically managed patients with good outcomes 
received 2 1.6 days of parenteral antibiotic therapy 
compared to 20.8 days for those with poor outcomes. All 
patients received oral antibiotics after parenteral antibi- 
otics were discontinued. These differences were not sig- 
nificant. 
Factors influencing outcome. Age appeared to 
significantly influence outcome in this series. There 
were 20 patients in the pediatric age group. Mean fol- 
lowup 2 years following joint infection indicated that 
good outcomes had occurred in 14 patients, poor out- 
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comes in 3, and 3 patients had been lost to followup. 
The 12 cases treated surgically had good outcomes, 
while 2 of 5 patients treated medically had good out- 
comes. The 3 medical failures had severe underlying ill- 
nesses. One neonate who died is described in Table 5. 
Another neonate was premature, had respiratory dis- 
tress syndrome, multiple cutaneous abscesses, and mi- 
crocephaly. The third patient was a 15-year-old girl 
with systemic lupus erythematosus who was taking high 
dose oral steroids and cyclophosphamide. None of the 
surgically treated patients had a serious underlying ill- 
ness. 
Influence of age was particularly evident in pa- 
tients with infection of the hip. Followup data .were ob- 
tained on 2 1 of 23 such patients. All of the good surgical 
results occurred in 9 patients under 16 years of age. The 
one poor outcome in this age group occurred in a 2-day- 
old infant where surgical drainage was delayed for 11 
days following admission. Four of the 6 adults treated 
surgically had infected prostheses. Five adult patients 
with hip infections were treated medically; 3 had good 
outcome, including a 73-year-old man with staphylo- 
coccal infection who had normal hip function when ex- 
amined 6 months after treatment of his infection. 
Type of organism. Of the 40 infected joints with 
only Gram-positive organisms isolated, 22 had good 
outcomes and 18 had poor outcomes. Of 16 patients 
with Gram-negative joint infections, followup data were 
available in 13 patients with 15 infected joints. Good 
outcomes occurred in 7 of 15 joints; 6 of these 7 joints 
were treated medically. Only 1 of 5 surgically treated 
joints had a good outcome. Seven patients had chronic 
debilitating illnesses (rheumatoid arthritis, chronic 
osteomyelitis, diabetes, or lymphoma). In addition, 3 
patients were taking oral corticosteroids (10-60 mg 
prednisone/day orally) at the time of joint infection. 
Two joints were infected with only anaerobic organ- 
isms. Both had good outcomes. In 4 cases, there were 
mixed aerobic-anaerobic infections. All had poor out- 
comes; 3 of these were in joints with infected prostheses. 
Host resistance. Patients suspected of being at in- 
creased risk of infection (patients taking oral corticoste- 
roids, patients who were immunologically suppressed, 
and/or had rheumatoid arthritis) were approximately 
evenly divided between the medically and surgically 
treated groups. Seven of 11 such patients treated medi- 
cally had good outcomes. None of the 10 “high risk” 
patients treated surgically had a good outcome (Table 
Rheumatoid arthritis patients. In this study, there 
were 9 patients with rheumatoid arthritis who devel- 
7). 
Table 7. Clinical outcome in specific groups of patients with non- 
gonococcal infectious arthritis 
Surgically treated Medically treated 
Good Poor Good Poor 
Oral cortico- 
steroids; 0 4 4 4 
Immunosuppressedt 0 3 1 2 
arthritis 0 6 3 0 
Gram-negative 
organisms 1 5 4 2 
infections 0 4 2 0 




* Greater than 10 mg prednisone (or equivalent) daily. 
t Diabetic, alcoholic, cytotoxic drugs, lymphoma, leukemia. 
oped acute joint infections. Three patients with 6 in- 
fected joints were treated medically and 6 patients with 
8 infected joints were treated initially with surgical 
drainage plus parenteral antibiotic therapy. The latter 
group included 3 patients with infected joint prostheses. 
The only good results occurred in patients who were 
treated medically. Coagulase-positive Staphylococcus 
was the infecting organism in 6 cases. In the other 3 pa- 
tients, Bacteroides, Peptostreptococcus, or Klebsiella 
species were identified as the infecting organism. One 
patient in this group died as a consequence of joint in- 
fection. One patient was receiving oral prednisone, 12 
mg/day, and 2 had received intraarticular steroid ther- 
apy in the joint that subsequently became infected. 
Prosthetic joints. Nine patients had 11 infected 
prostheses. Three joints were infected with coagulase- 
positive Staphylococcus. Group D Enterococci, coagu- 
lase-negative Staphylococci, and Clostridium chauvoei 
were isolated from 2 patients each. The other organisms 
involved were E coli, Bacteroides fragalis, Proteus, Pep- 
tostreptococcus, and Micrococcus. There were 2 pa- 
tients with multiple organisms. Four of 9 patients were 
initially treated with parenteral antibiotics alone; how- 
ever, all 4 required removal of the prostheses within l 
year due to persistent infection or pain. All 11 pros- 
theses had poor outcomes (Table 5). 
Medical failures. Three of 6 patients who failed 
to respond to parenteral antibiotics and repeated aspira- 
tions, and who subsequently underwent surgical drain- 
age, did well at followup at 4 weeks, 3 months, and 1 
year. One patient had a severe decrease in range of mo- 
tion of the involved joint at 6 weeks. One infant had 
failure of development of the femoral head at 4% years 
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of age, and one patient died secondary to sepsis. Four of 
the 6 patients had Staphylococcus aureus as the infecting 
organism. 
DISCUSSION 
The knee and hip were the most common sites of 
joint infection in this series. This is in agreement with 
most other series. In this series, medical management of 
an infected hip in adults had as good an outcome as sur- 
gical therapy; however, initial prompt surgical manage- 
ment of an infected hip in children and infants remains 
the therapy of choice. All of the children so treated in 
this series had good outcomes. 
Morrey, Bianco, and Rhodes (4) studied 103 pa- 
tients less than 17 years of age who had acute infectious 
arthritis. They noted one death in their series. Young 
children were reported to be more susceptible to Hemo- 
philus infuenzae and streptococcal infectious arthritis; S 
epidermidis was the infecting agent in 5 patients. They 
noted “few” Gram-negative organisms. Staphylococcus 
aureus was seen in approximately 50%, and Hemophilus 
infuenzae in 14% of their patients. Long term followup 
on 49 pediatric patients by Howard (20) for an average 
of 4.3 years demonstrated decreased range of joint mo- 
tion, shortening of the affected limb, and/or deformities 
of the affected joint in 27%; these sequelae were more 
common with hip and ankle disease. Physical findings 
at the time of hospital discharge identified only 31% of 
the patients who were found to be functionally impaired 
at a later date. These children with functional impair- 
ment usually were sicker for a longer period of time, 
and drainage was often delayed. In the current series, 
all children initially treated surgically had good out- 
comes. Followup at a mean of 2 years did not disclose 
any change in status from that documented at the time 
of hospital discharge. 
The occurrence of acute infectious arthritis has 
remained essentially constant during the last several 
decades. The coagulase-positive Staphylococcus is still 
the most prevalent nongonococcal organism responsible 
for joint infection. Most studies indicate that the fre- 
quency of gonococcal arthritis is equal to that of all 
other pyogens combined (2 1,22). At University Hospi- 
tal, approximately one-third of patients with acute in- 
fectious arthritis have gonococcal infection. This in- 
cidence is undoubtedly influenced by the patient 
population admitted at this institution. 
Anaerobic infections were more common in this 
study (6 patients) than previously reported. This may be 
due to the fact that 4 of the 8 anaerobes were isolated 
from 3 infected prostheses; in addition, 1 patient had 
decubitus ulcers, and 1 patient had rheumatoid arthritis 
and was receiving oral corticosteroids. Other series (1,4- 
6) did not include cases with infected prostheses. Zi- 
ment and associates (23) have commented upon anaero- 
bic joint infections. In a review of the literature, they 
found that no organism had been recovered in 16% of 
patients with presumed infectious arthritis. They com- 
mented upon the possibility that in some of these cases, 
anaerobic microorganisms may have been responsible 
for the infection. The sternoclavicular joint had a pecul- 
iar susceptibility to infection with Gram-negative an- 
aerobic bacilli. These authors felt that an anaerobic in- 
fection should be suspected if foul-smelling pus was 
noted, gas was detected on joint roentgenogram, or if 
the Gram stain was suggestive of Gram-negative pale 
staining pleomorphic rods (Bacteroides), or small 
Gram-positive cocci (which are more often anaerobic 
than aerobic). 
Infectious arthritis in patients with rheumatoid 
arthritis is an uncommon complication of a common 
disease. Its incidence in several studies of the rheuma- 
toid population varies from 0.3 to 3% (24-26). Infections 
have long been recognized as an important cause of 
morbidity and mortality in patients with rheumatoid ar- 
thritis (27). Multiple factors may contribute to increased 
susceptibility to superimposed infection in patients with 
rheumatoid arthritis. Neutrophil chemotaxis and 
phagocytosis have been reported to be decreased in the 
synovial fluid of patients with rheumatoid arthritis 
(28,29). 
In an early study of infectious arthritis in pa- 
tients with rheumatoid disease, Kellgren (30) noted that 
fever and leukocytosis in response to infection were of- 
ten blunted or absent. However, this has not been borne 
out by subsequent studies (25,26,3 1-33). The offending 
organism was a coagulase-positive Staphylococcus in 
most cases, and in the current series this microbe ac- 
counted for 76% of infections in the rheumatoid pa- 
tients. 
An infected joint in a patient with rheumatoid 
arthritis is a potentially catastrophic event. The com- 
bined death rate in the studies cited above was 18%. 
There was 1 death in 9 rheumatoid patients included in 
this study. In addition, only 3 of 12 infected joints in our 
patients with rheumatoid arthritis had good outcomes. 
Eftekhar (34) has stated that aggressive local 
treatment and use of intravenous antibiotics for 4 to 6 
weeks may save approximately 20% of patients with in- 
fected hip protheses. This author reported that with a 
subacute or chronic infection, a conservative approach 
is justified, and not all infected prosthetic hips require 
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an immediate decision to remove the artificial device. 
However, once it has been clinically and radiologically 
established that the total hip replacement is infected 
and the patient is symptomatic, the entire implant must 
be removed. Our population with infected prostheses is 
too small to state whether there is a 20% salvage rate. 
All 11 prostheses were removed in this series. Many pa- 
tients with prosthetic joints are elderly and/or immuno- 
suppressed. The risk of septicemia or metastatic infec- 
tion in this population would appear to warrant 
immediate removal of the foreign body in most in- 
stances. 
Positive blood cultures have been reported to be 
a poor prognostic sign in patients with acute joint infec- 
tion (1). In this series, 13 of 38 patients had positive 
blood cultures. There were followup data for 11 of these 
individuals, and 5 patients had good outcomes whereas 
6 had poor outcomes. However, it is important to note 
that 3 of the 6 with poor outcomes who had positive 
blood cultures died. 
In the current study, infections with Gram-nega- 
tive organisms did not significantly alter the outcome, 
but the presence of an anaerobic joint infection did. 
Only 2 of 6 patients in this category had good outcomes. 
Patients in the entire series were more likely to have 
poor outcomes if they were immunosuppressed, or had 
rheumatoid arthritis or an infected prosthesis. Outcome 
was also influenced by duration of symptoms prior to 
therapy. The average duration of symptoms in all pa- 
tients who eventually had good outcomes was 9 days, 
while in those with poor outcomes, it was 20.5 days. 
This again emphasizes the importance of early diagno- 
sis and treatment of the infected joint. The average du- 
ration of symptoms in patients with rheumatoid arthritis 
was 14 days, while for those with infected prostheses it 
was 28 days. Outcome was not influenced by the spe- 
cific joint which was the site of infection. 
The current medical literature supports the view 
that parenteral antibiotics easily reach bacteriocidal 
conoentrations in the synovial fluid (35,36) and that re- 
peated joint aspirations (9,37-40) are the preferred 
mode of local therapy, unless the pus is too thick, locu- 
lated, or the joint is inaccessible to aspiration. If steri- 
lization of the synovial fluid and clinical improvement 
are not evident in 5 to 7 days, then open drainage 
should be performed. This differs from the recommen- 
dations found in the surgical literature (1,4,34,41) where 
most authors feel that incision and drainage should be 
done within the first 1 or 2 days in adults, and immedi- 
ately in children with hip infections. The reason for rec- 
ommending immediate surgical drainage in hip infec- 
tions in the pediatric patient relates to the anatomy of 
the joint. The proximal end of the growing bone lies 
within the joint space, and an increase in intraarticular 
pressure leads to a rapid compromise of intracapsular 
blood supply. Morrey, Bianco, and Rhodes (4) suggest 
that the only indication for aspiration instead of arthrot- 
omy is infection of a joint other than the hip, and a 
prompt response to antibiotics, both parenteral and in- 
traarticular, within 12 hours. Kelly (41) indicates that 
the approach to local therapy is not critical if one is able 
to sterilize the joint with repeated aspirations and sys- 
temic antibiotics. In the current series, medically man- 
aged adult patients fared substantially better than surgi- 
cally treated patients. Good results with surgical 
therapy were limited to children. The lack of good out- 
come in surgically treated adult patients (excluding 
those with prostheses), when compared to medically 
treated patients, cannot be attributed to a significant 
difference in underlying diseases, duration of antibiotic 
therapy, or duration of symptoms prior to diagnosis. 
These results again emphasize that aggressive medical 
management in the adult is the preferred mode of ther- 
apy in most cases. 
A high index of suspicion for infectious arthritis 
must be maintained in all cases of joint inflammation. A 
suspected infected joint should be cultured for anaer- 
obes as well as aerobes if the patient has a prosthetic 
joint, is immunosuppressed, has rheumatoid arthritis, or 
has a distant infection that has a high probability of 
being anaerobic, such as lung or brain abscess. The lack 
of systemic symptoms by no means rules out an infected 
joint. Fever was noted in only 56% of patients in this se- 
ries at the time of presentation, and the classic signs of 
local inflammation of the joint were often absent. A pri- 
mary source of infection must be diligently and repeat- 
edly sought in all cases. Over one-half of our patients 
had an identifiable primary source of infection. An in- 
fected joint prosthesis, especially in an immuno- 
suppressed patient, should be immediately and com- 
pletely removed. 
Based upon this analysis of patients seen during 
a 6-year period (1972-77), we conclude that initial ther- 
apy for an infected joint should consist of aspiration as 
frequently as necessary (at least daily, initially), and 
high dosages of parenteral antibiotics. Frequent syno- 
vial fluid cell counts, Gram stains, and cultures of the 
synovial fluid should be obtained, as pointed out by 
others (3 1,39,40). Initial antibiotic therapy should be 
dictated by the results of the initial Gram stain. If no or- 
ganism is seen on Gram stain, until the results of culture 
are known the adult patient should be started on a drug 
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such as nafcillin that is effective against penicillinase- 
producing organisms, combined with an amino- 
glycoside if the clinical situation suggests the possibility 
of a Gram-negative infection or if the patient is immu- 
nosuppressed. A child should receive coverage against 
Hemophilus infuenzae as well as against penicillinase- 
producing staphylococci. Parenteral therapy should be 
continued for a minimum of 2 to 4 weeks in an un- 
complicated case, and for at least 4 weeks if the patient 
is immunosuppressed. If the organism is Pseudomonas, 
then the aminoglycoside should be combined with car- 
benicillin. If there is any question regarding the ade- 
quacy of medical management, synovial fluid should be 
tested by the serial tube dilution method and antibiotic 
concentrations should also be determined. If the pa- 
tient’s joint(s) remain(s) clinically infected, or if the sy- 
novial fluid white cell count does not decrease within 5 
to 7 days, open surgical drainage may need to be per- 
formed. Special consideration must be given to infec- 
tion of the sternoclavicular joint since it is commonly 
associated with osteomyelitis or abscess (13,17). In this 
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Rheumatology and Metabolic Bone Disease 
The Harvard Medical School Department of Continuing Education will present a course en- 
titled “Rheumatology and Metabolic Bone Disease” October 20-24, 1980 at the Parker House 
Hotel, Boston. Sponsored by The Massachusetts General Hospital, the course is designed for 
rheumatologists and internists with special interests in rheumatology and metabolic bone dis- 
eases, with emphasis on recent advances in pathogenesis and treatment. Directors for the pro- 
gram are Drs. Dwight R. Robinson, Kurt J. Bloch, Stephen M. Krane, and John A. Mills. 
Tuition is $360 (U.S.), and attendance is limited. Harvard Medical School certifies that this 
continuing education program meets the criteria for approximately 31 credit hours in Category I 
of the Physician’s Recognition Award of the AMA. 
Application forms and additional information may be obtained from Harvard Medical 
School, Department of Continuing Education, 25 Shattuck Street, Boston, MA 021 15. 
